1Department of Molecular Biology, University of Okara, Punjab, Pakistan.
2Department of Biochemistry, Faculty of Life Science, University of Okara, Punjab, Pakistan
In 2023, Pakistan faced a widespread outbreak of conjunctivitis, affecting nearly 400,000 individuals. The rapid transmission was driven by environmental factors, infectious agents, and allergens, with common symptoms including eye redness, swelling, tearing, and discharge. In response, a pioneering bioinformatics study examined the TLR4 gene variants, given TLR4 role in immune response, although direct genetic links to conjunctivitis are not yet established. Using Swiss Model and SAVESV6.1, a 3D model of TLR4 was developed, verified with a QMEAN-Z score of -0.81 and a ProSA score of -7.51, affirming its reliability. This study identified 82 highly deleterious nsSNPs through multiple computational tools, with 12 significantly harmful variants N44H, S207C, N185S, and D84A exhibiting notable structural impacts. Docking studies with both wild-type and mutant forms of TLR4 tested 17 compounds, revealing Apigenin, GN8, SYUIQ-5, S-adenosylmethionine, Vixotrigine, and Tetracycline as potential inhibitors due to their strong affinities for TLR4. These findings suggest that these compounds may offer therapeutic potential for conjunctivitis, though further experimental validation is needed.
Conjunctivitis is an inflammatory condition impacting the conjunctiva, the transparent membrane that covers the white of the eye and the inner eyelids. This condition is marked by symptoms such as excessive discharge, sensitivity to light, redness of the conjunctiva, and itching. Conjunctivitis can be triggered by multiple factors, including allergens, viral agents, and bacterial infections [1]. A recent ophthalmology study in the USA highlights that eye diseases treated in emergency departments incur an annual cost of $2 billion. Conjunctivitis alone contributes around 28% of this total, underscoring the substantial financial strain eye conditions place on healthcare resources [2]. Conjunctivitis can be caused by several viral pathogens, including the varicella-zoster virus (VZV), herpes simplex virus (HSV) and adenovirus [3]. Fungi are significant contributors to eye infections, especially in tropical and developing regions. They can cause severe ocular candidiasis and keratitis, which may result in permanent vision loss [4].Various bacteria, including Gram-positive types (Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, and Bacillus species), as well as Gram-negative (Pseudomonas aeruginosa, Moraxella, and Haemophilus spp.,) often cause conjunctivitis and keratitis. They may enter the eye through skin contact, the respiratory tract, or external infection from another person[4, 5]. Genetic variants influencing angiogenic responsiveness, such as the pink-eyed mutation in the oca2 gene, impact pink eye development in mice by altering angiogenesis. This mutation modifies blood vessel formation within the eye, contributing to changes associated with pink eye [6]. Allergic conjunctivitis is widespread, affecting between 15% and 40% of various populations. A study in Saudi Arabia found an age- and sex-adjusted prevalence of 70.5% among adults in the western region [7]. Pakistan reported 400,000 cases of viral conjunctivitis, with a particularly high surge in cases observed in Karachi [8]. Moreover, variants in the interleukin-4 gene (rs2243250) and its receptor (rs1805010) have been associated with viral conjunctivitis. Research has revealed significant differences in genotype distributions between viral conjunctivitis patients and healthy controls, suggesting these genetic variants may influence susceptibility to viral infections leading to conjunctivitis [9].
The genes associated with Herpes Simplex Virus Type 1 ocular infection include UL24, UL29 (ICP8), UL41 (VHS), UL53 (gK), UL54 (ICP27), UL56, ICP4, US1 (ICP22), US3, and gG, play critical roles in the virus’s replication, immune evasion, and ocular tissue damage during infection [3]. Toll-like receptor 4 (TLR4) is significant in the innate immune response by recognizing pathogen-associated molecular patterns (PAMPs) and initiating inflammatory signaling pathways. In allergic conjunctivitis, TLR4 can be activated by environmental allergens, such as pollen, dust mites, or pollutants, which are perceived as threats by the immune system [10]. The TLR4 (ARMD10 or CD284) gene is located on chromosome 9q32 in humans and is composed of several exons and introns, which are transcribed into mRNA and subsequently translated into the TLR4 protein. It spans multiple kilobases and is classified as a type I transmembrane protein, characterized by a single transmembrane domain that anchors it within the cell membrane. The extracellular domain of TLR4 plays a key role in recognizing PAMPs, such as lipopolysaccharides (LPS), while the intracellular domain is involved in triggering signaling pathways [11]. The extracellular region of TLR4 includes a leucine-rich repeat (LRR) motif, essential for binding ligands. This allows TLR4 to identify specific molecular signatures from pathogens, including bacterial LPS, which activates an immune response. The intracellular portion contains the TIR domain, which is responsible for initiating downstream signaling after activation. The TIR domain interacts with adaptor proteins, including MyD88 and TRIF, leading to the activation of inflammatory pathways such as NF-?B and MAPK, which ultimately results in the release of pro-inflammatory cytokines [12, 13]. Upon ligand binding, TLR4 typically dimerizes, often in conjunction with the co-receptor MD-2, which is necessary for LPS and other PAMP recognition. The TLR4 gene also undergoes alternative splicing, producing various isoforms that may have different functional characteristics or tissue-specific expression. Genetic variations in the TLR4 gene can alter its function and are linked to a range of conditions, including sepsis, autoimmune diseases, and allergic reactions [14].
Furthermore, TLR4 expression was detected in circulating CD4+ T cells from individuals with chronic allergic conjunctivitis, and in conjunctival epithelial cells. The D299G (rs4986790) and T399I have been studied and 18% TLR4 mutations, with a significantly higher incidence of gram-negative infections that may contribute to an increased susceptibility to allergic conjunctivitis [15, 16]. When peripheral blood mononuclear cells (PBMCs) from patients were stimulated with allergens such as Der p, a significant increase in both TLR4 expression and activation markers (CD69) was observed in CD4+ T cells. This suggests that allergen-specific stimulation can enhance the TLR4 activity, which may contribute to the Th2 inflammatory microenvironment commonly seen in allergic responses [15]. Bioinformatics tools play a crucial role in understanding the genetic foundations of infectious diseases, which is essential for early detection of eye infections and effective epidemiological responses. By utilizing a range of prediction tools, we categorized the nsSNPs in the TLR4 gene and identified those most likely to disrupt receptor function, potentially leading to diseases such as conjunctivitis. Future research will focus on exploring the in-silico structural and functional effects of missense mutations in human TLR4, specifically with pink eye infections. This approach will aim to identify potential treatment targets and enhance drug precision. Such strategies hold promises for improving treatment efficacy and developing preventative measures to reduce infection rates.
2.1 Screening datasets
The National Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov) has made available the hTLR4 gene data, including unique SNP findings, through their dbSNP database (http://www.ncbi.nlm.nih.gov/snp). Additionally, UniProt (https://www.uniprot.org) is used to obtain protein sequence information, allowing for detailed insights into its structure and function. The Overall methodology of the present study is given in Figure 1.

Figure 1. Workflow of the current study
2.2 Prediction of nsSNPs
SNPNexus tool (https://www.snp-nexus.org/v4) simplifies the selection and prioritization of known and novel genomic variants [17]. Sorting Intolerant From Tolerant (SIFT) uses sequence homology to identify deleterious SNPs, analyzing amino acid variations that affect protein phenotypic and functional alterations [18]. PolyPhen analyzes protein composition and functionality by analyzing amino acid substitutions using protein sequence, and substitution information. The score ranges from 0.0 to 1.0 indicating deleterious or tolerated variants [19]. Protein Analysis through Evolutionary Relationship (PANTHER) (https://www.pantherdb.org/tools) uses evolutionary relationships and the Hidden Markov Model (HMM) for analysis [20]. The TLR4 sequence, mutant, and position are submitted to the query [21]. Amino acid substitutions on functional proteins are categorized as benign or harmful by the web server MutPred2 (http://mutpred2.mutdb.org), with "pathogenic mutation" values ranging from 0.5 to 1.0 [22]. Polyphen-2-Polymorphism Phenotyping v2 (http://genetics.bwh.harvard.edu/pph2/) predicts the consequence of an amino acid substitution on a protein's structure and, hence, function [23]. The PredictSNP (https://loschmidt.chemi.muni.cz/predictsnp1) uses input data from various tools to predict the impact of changing one amino acid, offering increased effectiveness and accuracy [24].
2.3 Impact of disease-associated nsSNPs on protein stability.
SuSpect (http://www.sbg.bio.ic.ac.uk/suspect) analyzes disease prediction using sequence-based and annotation methods, reducing annotation bias and ranking genes based on multiple evidence lines [25]. SNPs & GO (https://snps.biofold.org/snps-and-go/snps-and-go.html) uses functional annotation of protein sequences to determine variation associated with a disease [22]. Meta SNP (https://snps.biofold.org/meta-snp) is used to predict a single nucleotide variation in protein sequence. The output value>0.5 is considered as a disease, and <0>[26]. iStable (http://predictor.nchu.edu.tw/iStable) is a server that predicts protein stability changes using sequence or structure information, combining five forecasting instruments and a variety of feature coding and prediction techniques [27].
2.4 Homology Modeling Prediction
The SWISS-MODEL algorithm (https://swissmodel.expasy.org) is used for protein structural homology modeling that constructs accurate protein structures by utilizing closely related templates. The process begins by clustering known protein structures and selecting the template with the highest sequence identity to the target protein [28]. Following model construction, SWISS-MODEL evaluates the model's quality using several validation metrics, including the Ramachandran plot, QMEAN score, and MolProbity score. These assessments provide insights into the geometric quality and reliability of the predicted structure [29].
2.5 Structural Verification Analysis
SAVESv6.1 (https://saves.mbi.ucla.edu) was used to select and validate a structural model, incorporating PROCHECK and ERRAT for overall quality. A RAMACHANDRAN plot assessed model quality, determining the amino acid preferred area and dihedral angle. This plot of the torsional angles phi (?) and psi (?) of the residues (amino acids) contained in a peptide. By Ramachandran plot helps to determine which torsional angles are permitted and can obtain insight into the structure of peptides. The model with satisfying stereo-chemical quality was further assessed by QMEAN and ProSA was used to compute Z score values for the models [30].
2.6 Structural Superimposition
Template Modeling alignment (TM-Align) tool (https://zhanggroup.org/TM-align) used for comparing the structural similarities between wild-type and mutant protein models. It calculates the TM-score and Root Mean Square Deviation (RMSD) to assess the degree of structural divergence quantitatively [31]. In contrast, RMSD quantifies the average distance between corresponding atoms in the aligned proteins; higher RMSD values signify greater structural divergence [32].
2.7 Structural analysis of variants
Mutation 3D (http://www.mutation3d.org/about.shtml) is a valuable computational tool designed to analyze the effects of amino acid substitutions on protein models and structures. This platform facilitates the identification of mutation clusters and functional hotspots, contributing to a deeper understanding of the implications of these alterations on protein function. The HOPE (Have (y) Our Protein Explained) program (https://www3.cmbi.umcn.nl/hope/input) collects details from multiple sources to offer insights into the effects of variants on TLR4 structure. After the FASTA format is submitted, it finds the mutant residue and goes on to the following step of analysis [33].
2.8 Ligand Preparation
PubChem (https://pubchem.ncbi.nlm.nih.gov) is a comprehensive database that houses a wide range of chemical compounds, primarily small molecules, but also includes larger compounds such as lipids, peptides, carbohydrates, nucleotides, and chemically modified macromolecules. It provides detailed information on chemical structures, identifiers, chemical and physical properties, biological activities, patents, and health, safety, and toxicological data [34].
2.9 Molecular screening analysis
PyRx (https://pyrx.sourceforge.io) is a virtual screening tool used in computational drug discovery to evaluate libraries of compounds for potential therapeutic targets. It allows users to perform Virtual Screening on various platforms, guiding them through each step of the process from data preparation to job submission and result analysis. Discovery Studio Visualizer (https://discover.3ds.com/discovery-studio-visualizer-download) was then employed to examine the ligand-protein interactions, and both the ligand and protein structures were represented in 2D and 3D formats as PNG files for visualization. This workflow enables efficient drug discovery by predicting molecular interactions and identifying potential drug candidates [35].
RESULTS
In this study, a total of 8,702 SNPs of the human TLR4 gene were downloaded from the dbNCBI database. These SNPs include 4,275 in UTR regions, with 3,824 located in the 3' UTR region and 451 in the 5' UTR region. There are also 15,843 SNPs in intronic regions, 799 synonymous variants, and 1,928 non-synonymous SNPs. Additionally, the dataset comprises 2,601 SNPs in the 3' downstream region, 2,902 SNPs in the 5' upstream region, 157 exonic mutations, and 208 SNPs in non-coding regions, as illustrated in Figure 2. For further analysis, the protein sequence of O00206 was retrieved from the UniProt database. The human TLR4 gene is located in the 9q33.1 region of chromosome 9. It has a molecular weight of 95 kDa and consists of 4 exons and 10 distinct introns.

Figure 2. Bar Plot presents the SNPs in different regions of the TLR4 Gene.
3.2 Functional Prediction of nsSNPs
A total of 8,702 rsIDs were submitted to SNPnexus, resulting in predictions for 1,724 variants, with 878 classified as deleterious and 972 as tolerated based on the SIFT algorithm (Figure 3a). Additionally, PolyPhen analysis revealed that 469 nsSNPs were likely to be damaging, 355 were categorized as possibly damaging, and 1,026 were identified as benign (Figure 3b). Among these, 132 SNPs were found to be common and were all predicted to be probably damaging (Table 1). These findings highlight the potential significance of these variants in terms of their impact on protein function and their possible associations with disease.

Figure 3. Detrimental missense nsSNPs are predicted by a) SIFT algorithm 0 and b) PolyPhen
Table 1. Prediction of functional consequences of coding variants identified by SNPnexus
|
Variation ID |
Mutation |
Polyphen |
SIFT |
Variation ID |
Mutation |
Polyphen |
SIFT |
||||
|
Score |
Prediction |
Score |
Prediction |
Score |
Prediction |
Score |
Prediction |
||||
|
rs1383009042 |
P145L |
0.911 |
PD |
0 |
D |
rs776282454 |
G699R |
0.993 |
PD |
0 |
D |
|
rs755813457 |
I320T |
0.911 |
PD |
0 |
D |
rs1157906794 |
G715V |
0.993 |
PD |
0 |
D |
|
rs55786277 |
R804W |
0.913 |
PD |
0 |
D |
rs200905500 |
R787H |
0.993 |
PD |
0 |
D |
|
rs137853920 |
C281Y |
0.915 |
PD |
0 |
D |
rs377719663 |
Y709C |
0.994 |
PD |
0.01 |
D |
|
rs200246890 |
N205H |
0.922 |
PD |
0 |
D |
rs892362464 |
L59M |
0.995 |
PD |
0 |
D |
|
rs199930089 |
G715R |
0.924 |
PD |
0 |
D |
rs201521400 |
F237L |
0.996 |
PD |
0 |
D |
|
rs1044303225 |
V32A |
0.929 |
PD |
0 |
D |
rs199763503 |
L658R |
0.996 |
PD |
0 |
D |
|
rs1038463767 |
V735F |
0.93 |
PD |
0 |
D |
rs1194635312 |
Y674C |
0.996 |
PD |
0 |
D |
|
rs1416546558 |
N690S |
0.932 |
PD |
0.01 |
D |
rs754642038 |
V736A |
0.996 |
PD |
0 |
D |
|
rs773429738 |
L335I |
0.933 |
PD |
0 |
D |
rs777803994 |
L802Q |
0.996 |
PD |
0 |
D |
|
rs757953593 |
I247T |
0.935 |
PD |
0 |
D |
rs1363147767 |
G252S |
0.997 |
PD |
0 |
D |
|
rs1159116911 |
T151I |
0.936 |
PD |
0 |
D |
rs1194292799 |
S455T |
0.997 |
PD |
0 |
D |
|
rs201114738 |
S381G |
0.939 |
PD |
0 |
D |
rs1194292799 |
S415T |
0.997 |
PD |
0 |
D |
|
rs1163840909 |
E31V |
0.94 |
PD |
0 |
D |
rs80197996 |
L470F |
0.997 |
PD |
0 |
D |
|
rs370421152 |
V134L |
0.94 |
PD |
0 |
D |
rs200787883 |
F492V |
0.997 |
PD |
0 |
D |
|
rs762970720 |
V736L |
0.946 |
PD |
0 |
D |
rs55905951 |
A676G |
0.997 |
PD |
0 |
D |
|
rs1472004859 |
L117S |
0.947 |
PD |
0 |
D |
rs761598705 |
H708R |
0.997 |
PD |
0 |
D |
|
rs199666264 |
R257P |
0.949 |
PD |
0 |
D |
rs750790595 |
R787C |
0.997 |
PD |
0.01 |
D |
|
rs55799839 |
L260P |
0.95 |
PD |
0 |
D |
rs769239861 |
R87S |
0.998 |
PD |
0 |
D |
|
rs759420110 |
L571I |
0.952 |
PD |
0.01 |
D |
rs56302444 |
I93V |
0.998 |
PD |
0.03 |
D |
|
rs749872850 |
E685G |
0.952 |
PD |
0.01 |
D |
rs370421152 |
V134M |
0.998 |
PD |
0 |
D |
|
rs747209292 |
K694N |
0.952 |
PD |
0 |
D |
rs188543451 |
L138P |
0.998 |
PD |
0 |
D |
|
rs201835255 |
R257C |
0.954 |
PD |
0.01 |
D |
rs993554067 |
L208F |
0.998 |
PD |
0 |
D |
|
rs766151559 |
F516I |
0.955 |
PD |
0 |
D |
rs2770145 |
C306W |
0.998 |
PD |
0 |
D |
|
rs368003192 |
R810L |
0.957 |
PD |
0.01 |
D |
rs770682940 |
N361K |
0.998 |
PD |
0.01 |
D |
|
rs1235644534 |
N44H |
0.961 |
PD |
0 |
D |
rs765968259 |
N721S |
0.998 |
PD |
0.02 |
D |
|
rs769767782 |
V132L |
0.964 |
PD |
0.01 |
D |
rs1258063271 |
A754V |
0.998 |
PD |
0 |
D |
|
rs1301599599 |
V32M |
0.965 |
PD |
0.05 |
D |
rs748382304 |
I769T |
0.998 |
PD |
0 |
D |
|
rs199561420 |
S441L |
0.965 |
PD |
0 |
D |
rs55751501 |
A814T |
0.998 |
PD |
0.01 |
D |
|
rs56101219 |
I722V |
0.968 |
PD |
0 |
D |
rs1301599599 |
V32L |
0.999 |
PD |
0.05 |
D |
|
rs61734367 |
N361D |
0.97 |
PD |
0.01 |
D |
rs201613484 |
L104F |
0.999 |
PD |
0 |
D |
|
rs775401427 |
P49S |
0.972 |
PD |
0 |
D |
rs200168998 |
I162T |
0.999 |
PD |
0 |
D |
|
rs754342091 |
Y98C |
0.972 |
PD |
0 |
D |
rs77214890 |
D181Y |
0.999 |
PD |
0 |
D |
|
rs765289408 |
S105C |
0.973 |
PD |
0.03 |
D |
rs759469467 |
I187S |
0.999 |
PD |
0 |
D |
|
rs972966550 |
L511W |
0.975 |
PD |
0 |
D |
rs1440077974 |
L233S |
0.999 |
PD |
0 |
D |
|
rs1445128804 |
G765D |
0.975 |
PD |
0.01 |
D |
rs777887873 |
L401Q |
0.999 |
PD |
0 |
D |
|
rs1480203162 |
L375F |
0.976 |
PD |
0 |
D |
rs777887873 |
L401P |
0.999 |
PD |
0 |
D |
|
rs1480203162 |
L335F |
0.976 |
PD |
0 |
D |
rs201792813 |
Y652C |
0.999 |
PD |
0 |
D |
|
rs954875750 |
F237S |
0.977 |
PD |
0 |
D |
rs751229651 |
V678A |
0.999 |
PD |
0 |
D |
|
rs917000574 |
G279S |
0.978 |
PD |
0.01 |
D |
rs751229651 |
V638A |
0.999 |
PD |
0 |
D |
|
rs1256844267 |
T756P |
0.979 |
PD |
0 |
D |
rs779420060 |
W687R |
0.999 |
PD |
0 |
D |
|
rs780472681 |
S762I |
0.979 |
PD |
0.01 |
D |
rs1174477453 |
V688L |
0.999 |
PD |
0 |
D |
|
rs762746728 |
L307F |
0.98 |
PD |
0.03 |
D |
rs1282672274 |
G699V |
0.999 |
PD |
0 |
D |
|
rs1353182806 |
G726S |
0.98 |
PD |
0 |
D |
rs56101219 |
I722F |
0.999 |
PD |
0 |
D |
|
rs56380595 |
P823T |
0.98 |
PD |
0.02 |
D |
rs746352626 |
G726D |
0.999 |
PD |
0 |
D |
|
rs897794510 |
S207C |
0.981 |
PD |
0 |
D |
rs746352626 |
G726V |
0.999 |
PD |
0 |
D |
|
rs902036821 |
D194N |
0.982 |
PD |
0.02 |
D |
rs1287623116 |
S744G |
0.999 |
PD |
0 |
D |
|
rs1314441656 |
Q430P |
0.983 |
PD |
0 |
D |
rs1048072828 |
T793A |
0.999 |
PD |
0 |
D |
|
rs1216019140 |
C340W |
0.984 |
PD |
0 |
D |
rs779025130 |
C40Y |
1 |
PD |
0 |
D |
|
rs2770144 |
V310G |
0.985 |
PD |
0 |
D |
rs868027365 |
D84N |
1 |
PD |
0 |
D |
|
rs202114774 |
L519V |
0.985 |
PD |
0 |
D |
rs760962514 |
D84A |
1 |
PD |
0 |
D |
|
rs199632399 |
R745C |
0.985 |
PD |
0 |
D |
rs1044303225 |
C88R |
1 |
PD |
0 |
D |
|
rs766243776 |
N309Y |
0.986 |
PD |
0 |
D |
rs766539584 |
L152V |
1 |
PD |
0 |
D |
|
rs748810494 |
V134A |
0.987 |
PD |
0 |
D |
rs537921846 |
N160S |
1 |
PD |
0 |
D |
|
rs202040652 |
T793I |
0.987 |
PD |
0 |
D |
rs1281579352 |
P168H |
1 |
PD |
0 |
D |
|
rs199930089 |
G715S |
0.988 |
PD |
0 |
D |
rs1296130154 |
N185S |
1 |
PD |
0 |
D |
|
rs988829747 |
I742T |
0.988 |
PD |
0 |
D |
rs371871286 |
N213K |
1 |
PD |
0 |
D |
|
rs201897073 |
I146T |
0.989 |
PD |
0 |
D |
rs371871286 |
N173K |
1 |
PD |
0 |
D |
|
rs919321567 |
L372Q |
0.989 |
PD |
0.01 |
D |
rs202089517 |
S407T |
1 |
PD |
0.04 |
D |
|
rs1394250328 |
I742F |
0.989 |
PD |
0.01 |
D |
rs934780727 |
N409S |
1 |
PD |
0 |
D |
|
rs376443096 |
D428N |
0.99 |
PD |
0 |
D |
rs764148809 |
L452R |
1 |
PD |
0 |
D |
|
rs1382563975 |
V716M |
0.99 |
PD |
0 |
D |
rs201456149 |
D453G |
1 |
PD |
0 |
D |
|
rs373109368 |
L182V |
0.992 |
PD |
0.01 |
D |
rs1285033378 |
C585Y |
1 |
PD |
0 |
D |
|
rs1388911129 |
L779F |
0.992 |
PD |
0 |
D |
rs1354283847 |
C609Y |
1 |
PD |
0 |
D |
|
rs200139449 |
G803V |
0.992 |
PD |
0 |
D |
rs1233324596 |
C609W |
1 |
PD |
0 |
D |
|
rs1346126850 |
N481D |
0.993 |
PD |
0 |
D |
rs200497661 |
R731Q |
1 |
PD |
0 |
D |
*D=Deleterious; PD= Probably Damaging
3.3 Prediction of functional impact of mutation
The analysis of nsSNPs using PANTHER, Predict SNP, and PolyPhen2 revealed significant insights into their potential impact on protein function (Table 2). PANTHER classified 96 nsSNPs as Possibly Damaging, 28 as Probably Benign, and 8 as Probably Damaging, with specific mutations (R810L, C306W, and L401Q) identified as likely impairing protein function. Predict SNP found 104 SNPs to have a detrimental effect and 28 to be neutral. PolyPhen2 predicted all 128 SNPs to be Probably Damaging, with a few exceptions, such as S415T, I769T, and P168H, which were considered benign, and Y652C, which was marked as possibly damaging. These results suggest that many of the nsSNPs may have a detrimental effect on protein function, warranting further experimental investigation.
Table 2. List of disease linked variants predicted by computational tools.
|
Variation ID |
Mutation |
PANTHER |
Polyphen2 |
Predict SNP |
||
|
Score |
Prediction |
Score |
Prediction |
Prediction |
||
|
rs1383009042 |
P145L |
0.5 |
Possibly Damaging |
0.992 |
Probably Damaging |
Neutral |
|
rs755813457 |
I320T |
0.19 |
Probably Benign |
0.965 |
Probably Damaging |
Deleterious |
|
rs55786277 |
R804W |
0.13 |
Probably Benign |
0.999 |
Probably Damaging |
Deleterious |
|
rs137853920 |
C281Y |
0.5 |
Possibly Damaging |
0.998 |
Probably Damaging |
Deleterious |
|
rs200246890 |
N205H |
0.5 |
Possibly Damaging |
0.998 |
Probably Damaging |
Deleterious |
|
rs199930089 |
G715R |
0.5 |
Possibly Damaging |
0.992 |
Probably Damaging |
Deleterious |
|
rs1044303225 |
V32A |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1038463767 |
V735F |
0.5 |
Possibly Damaging |
0.986 |
Probably Damaging |
Neutral |
|
rs1416546558 |
N690S |
0.27 |
Probably Benign |
0.988 |
Probably Damaging |
Neutral |
|
rs773429738 |
L335I |
0.5 |
Possibly Damaging |
0.992 |
Probably Damaging |
Neutral |
|
rs757953593 |
I247T |
0.5 |
Possibly Damaging |
0.982 |
Probably Damaging |
Neutral |
|
rs1159116911 |
T151I |
0.27 |
Probably Benign |
0.965 |
Probably Damaging |
Deleterious |
|
rs201114738 |
S381G |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Neutral |
|
rs1163840909 |
E31V |
0.19 |
Probably Benign |
0.801 |
Probably Damaging |
Deleterious |
|
rs370421152 |
V134L |
0.5 |
Possibly Damaging |
0.941 |
Probably Damaging |
Neutral |
|
rs762970720 |
V736L |
0.5 |
Possibly Damaging |
0.972 |
Probably Damaging |
Deleterious |
|
rs1472004859 |
L117S |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs199666264 |
R257P |
0.27 |
Probably Benign |
1 |
Probably Damaging |
Deleterious |
|
rs55799839 |
L260P |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1235644534 |
N44H |
0.13 |
Probably Benign |
0.999 |
Probably Damaging |
Deleterious |
|
rs759420110 |
L571I |
0.5 |
Possibly Damaging |
0.992 |
Probably Damaging |
Deleterious |
|
rs749872850 |
E685G |
0.5 |
Possibly Damaging |
0.996 |
Probably Damaging |
Deleterious |
|
rs747209292 |
K694N |
0.5 |
Possibly Damaging |
0.996 |
Probably Damaging |
Deleterious |
|
rs201835255 |
R257C |
0.27 |
Probably Benign |
1 |
Probably Damaging |
Deleterious |
|
rs766151559 |
F516I |
0.85 |
Possibly Damaging |
0.998 |
Probably Damaging |
Deleterious |
|
rs368003192 |
R810L |
0.5 |
Possibly Damaging |
0.996 |
Probably Damaging |
Deleterious |
|
rs769767782 |
V132L |
0.5 |
Possibly Damaging |
0.979 |
Probably Damaging |
Neutral |
|
rs1301599599 |
V32M |
0.27 |
Possibly Damaging |
0.996 |
Probably Damaging |
Deleterious |
|
rs199561420 |
S441L |
0.5 |
Probably Benign |
0.972 |
Probably Damaging |
Neutral |
|
rs56101219 |
I722V |
0.27 |
Possibly Damaging |
0.994 |
Probably Damaging |
Deleterious |
|
rs61734367 |
N361D |
0.5 |
Probably Benign |
0.999 |
Probably Damaging |
Deleterious |
|
rs775401427 |
P49S |
0.27 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs754342091 |
Y98C |
0.5 |
Probably Benign |
1 |
Probably Damaging |
Deleterious |
|
rs765289408 |
S105C |
0.19 |
Possibly Damaging |
0.998 |
Probably Damaging |
Deleterious |
|
rs972966550 |
L511W |
0.5 |
Probably Benign |
0.996 |
Probably Damaging |
Deleterious |
|
rs1445128804 |
G765D |
0.5 |
Possibly Damaging |
0.996 |
Probably Damaging |
Neutral |
|
rs1480203162 |
L375F |
0.5 |
Possibly Damaging |
0.997 |
Probably Damaging |
Deleterious |
|
rs1480203162 |
L335F |
0.5 |
Possibly Damaging |
0.719 |
Probably Damaging |
Deleterious |
|
rs954875750 |
F237S |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs917000574 |
G279S |
0.5 |
Possibly Damaging |
0.993 |
Probably Damaging |
Neutral |
|
rs1256844267 |
T756P |
0.5 |
Possibly Damaging |
0.999 |
Probably Damaging |
Deleterious |
|
rs780472681 |
S762I |
0.5 |
Possibly Damaging |
0.999 |
Probably Damaging |
Deleterious |
|
rs762746728 |
L307F |
0.5 |
Possibly Damaging |
0.995 |
Probably Damaging |
Neutral |
|
rs1353182806 |
G726S |
0.5 |
Possibly Damaging |
0.998 |
Probably Damaging |
Neutral |
|
rs56380595 |
P823T |
0.27 |
Possibly Damaging |
0.999 |
Probably Damaging |
Neutral |
|
rs897794510 |
S207C |
0.5 |
Probably Benign |
0.999 |
Probably Damaging |
Deleterious |
|
rs902036821 |
D194N |
0.5 |
Possibly Damaging |
0.978 |
Probably Damaging |
Neutral |
|
rs1314441656 |
Q430P |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1216019140 |
C340W |
0.19 |
Possibly Damaging |
0.997 |
Probably Damaging |
Deleterious |
|
rs2770144 |
V310G |
0.5 |
Probably Benign |
0.999 |
Probably Damaging |
Deleterious |
|
rs202114774 |
L519V |
0.5 |
Possibly Damaging |
0.999 |
Probably Damaging |
Deleterious |
|
rs199632399 |
R745C |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs766243776 |
N309Y |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs748810494 |
V134A |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Neutral |
|
rs202040652 |
T793I |
0.5 |
Possibly Damaging |
0.999 |
Probably Damaging |
Deleterious |
|
rs199930089 |
G715S |
0.27 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs988829747 |
I742T |
0.5 |
Probably Benign |
0.999 |
Probably Damaging |
Deleterious |
|
rs201897073 |
I146T |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs919321567 |
L372Q |
0.27 |
Possibly Damaging |
0.999 |
Probably Damaging |
Deleterious |
|
rs1394250328 |
I742F |
0.5 |
Probably Benign |
0.978 |
Probably Damaging |
Neutral |
|
rs376443096 |
D428N |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Neutral |
|
rs1382563975 |
V716M |
0.27 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs373109368 |
L182V |
0.5 |
Probably Benign |
1 |
Probably Damaging |
Deleterious |
|
rs1388911129 |
L779F |
0.27 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs200139449 |
G803V |
0.27 |
Probably Benign |
1 |
Probably Damaging |
Deleterious |
|
rs1346126850 |
N481D |
0.5 |
Probably Benign |
0.999 |
Probably Damaging |
Deleterious |
|
rs776282454 |
G699R |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1157906794 |
G715V |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs200905500 |
R787H |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs377719663 |
Y709C |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs892362464 |
L59M |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs201521400 |
F237L |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs199763503 |
L658R |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1194635312 |
Y674C |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Neutral |
|
rs754642038 |
V736A |
0.27 |
Possibly Damaging |
1 |
Probably Damaging |
Neutral |
|
rs777803994 |
L802Q |
0.5 |
Probably Benign |
1 |
Probably Damaging |
Deleterious |
|
rs1363147767 |
G252S |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Neutral |
|
rs1194292799 |
S455T |
0.27 |
Possibly Damaging |
0 |
Probably Damaging |
Deleterious |
|
rs1194292799 |
S415T |
0.27 |
Probably Benign |
1 |
Benign |
Deleterious |
|
rs80197996 |
L470F |
0.5 |
Probably Benign |
1 |
Probably Damaging |
Deleterious |
|
rs200787883 |
F492V |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs55905951 |
A676G |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs761598705 |
H708R |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Neutral |
|
rs750790595 |
R787C |
0.5 |
Possibly Damaging |
0.999 |
Probably Damaging |
Neutral |
|
rs769239861 |
R87S |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs56302444 |
I93V |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs370421152 |
V134M |
0.27 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs188543451 |
L138P |
0.5 |
Probably Benign |
1 |
Probably Damaging |
Deleterious |
|
rs993554067 |
L208F |
0.74 |
Possibly Damaging |
0.999 |
Probably Damaging |
Deleterious |
|
rs2770145 |
C306W |
0.27 |
Probably Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs770682940 |
N361K |
0.5 |
Probably Benign |
0.999 |
Probably Damaging |
Deleterious |
|
rs765968259 |
N721S |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1258063271 |
A754V |
0.5 |
Possibly Damaging |
0.126 |
Probably Damaging |
Deleterious |
|
rs748382304 |
I769T |
0.5 |
Possibly Damaging |
1 |
Benign |
Neutral |
|
rs55751501 |
A814T |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1301599599 |
V32L |
0.74 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs201613484 |
L104F |
0.5 |
Probably Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs200168998 |
I162T |
0.27 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs77214890 |
D181Y |
0.5 |
Probably Benign |
1 |
Probably Damaging |
Deleterious |
|
rs759469467 |
I187S |
0.27 |
Possibly Damaging |
1.000 |
Probably Damaging |
Deleterious |
|
rs1440077974 |
L233S |
0.74 |
Probably Benign |
1 |
Probably Damaging |
Deleterious |
|
rs777887873 |
L401Q |
0.74 |
Probably Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs777887873 |
L401P |
0.5 |
Probably Damaging |
0.534 |
Probably Damaging |
Deleterious |
|
rs201792813 |
Y652C |
0.5 |
Possibly Damaging |
1 |
Possibly Damaging |
Neutral |
|
rs751229651 |
V678A |
0.27 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs751229651 |
V638A |
0.5 |
Probably Benign |
1 |
Probably Damaging |
Deleterious |
|
rs779420060 |
W687R |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1174477453 |
V688L |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1282672274 |
G699V |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs56101219 |
I722F |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs746352626 |
G726D |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs746352626 |
G726V |
0.5 |
Possibly Damaging |
1.000 |
Probably Damaging |
Deleterious |
|
rs1287623116 |
S744G |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Neutral |
|
rs1048072828 |
T793A |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs779025130 |
C40Y |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs868027365 |
D84N |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs760962514 |
D84A |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1044303225 |
C88R |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs766539584 |
L152V |
0.74 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs537921846 |
N160S |
0.5 |
Possibly Damaging |
0.258 |
Probably Damaging |
Deleterious |
|
rs1281579352 |
P168H |
0.5 |
Possibly Damaging |
0.999 |
Benign |
Neutral |
|
rs1296130154 |
N185S |
0.74 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs371871286 |
N213K |
0.27 |
Probably Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs371871286 |
N173K |
0.5 |
Probably Benign |
1 |
Probably Damaging |
Deleterious |
|
rs202089517 |
S407T |
0.74 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs934780727 |
N409S |
0.5 |
Probably Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs764148809 |
L452R |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs201456149 |
D453G |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1285033378 |
C585Y |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1354283847 |
C609Y |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs1233324596 |
C609W |
0.5 |
Possibly Damaging |
1 |
Probably Damaging |
Deleterious |
|
rs200497661 |
R731Q |
0.5 |
Possibly Damaging |
0.877 |
Probably Damaging |
Neutral |
Using SNP &Go, SuSpect, and Meta SNP, the phenotypic impact of nsSNPs on the TLR4 gene was predicted (Table 3). SNP &Go identified 118 substitutions as neutral and 14 as disease-associated. The Meta SNP server also linked 90 SNPs to diseases and identified 42 as neutral. SuSpect predicted 132 nsSNPs as disease-causing. Any SNP marked as neutral by these tools was excluded from further analysis. Functional analysis of the remaining 132 nsSNPs showed that they have deleterious, probably damaging, or disease-causing effects on the TLR4 protein. Using the i-stable tool, which assesses changes in protein thermal stability, 111 SNPs were found to reduce stability, while 21 SNPs showed an increase in stability.
Table 3. Prediction of disease associated nsSNPs and Protein Stability change prediction
|
Variation ID |
Mutation |
SNP & GO |
SuSpect |
Meta SNP |
i stable |
|||
|
Score |
Effect |
Score |
Score |
Effect |
Stability |
Conf. score |
||
|
rs1383009042 |
P145L |
9 |
Neutral |
54 |
0 |
Neutral |
Decrease |
0.800778 |
|
rs755813457 |
I320T |
9 |
Neutral |
88 |
3 |
Neutral |
Decrease |
0.875835 |
|
rs55786277 |
R804W |
1 |
Neutral |
85 |
6 |
Disease |
Decrease |
0.735661 |
|
rs137853920 |
C281Y |
6 |
Neutral |
79 |
5 |
Neutral |
Increase |
0.761752 |
|
rs200246890 |
N205H |
10 |
Neutral |
70 |
1 |
Neutral |
Decrease |
0.807955 |
|
rs199930089 |
G715R |
2 |
Disease |
91 |
9 |
Disease |
Increase |
0.59246 |
|
rs1044303225 |
V32A |
9 |
Neutral |
42 |
6 |
Neutral |
Decrease |
0.831297 |
|
rs1038463767 |
V735F |
7 |
Neutral |
78 |
1 |
Disease |
Decrease |
0.862233 |
|
rs1416546558 |
N690S |
8 |
Neutral |
60 |
0 |
Neutral |
Decrease |
0.889097 |
|
rs773429738 |
L335I |
6 |
Neutral |
77 |
1 |
Neutral |
Increase |
0.519921 |
|
rs757953593 |
I247T |
8 |
Neutral |
77 |
7 |
Neutral |
Decrease |
0.824498 |
|
rs1159116911 |
T151I |
8 |
Neutral |
84 |
2 |
Neutral |
Decrease |
0.82995 |
|
rs201114738 |
S381G |
9 |
Neutral |
79 |
0 |
Neutral |
Decrease |
0.863368 |
|
rs1163840909 |
E31V |
9 |
Neutral |
54 |
5 |
Neutral |
Decrease |
0.838044 |
|
rs370421152 |
V134L |
9 |
Neutral |
49 |
2 |
Neutral |
Decrease |
0.509748 |
|
rs762970720 |
V736L |
7 |
Neutral |
89 |
2 |
Neutral |
Decrease |
0.86035 |
|
rs1472004859 |
L117S |
5 |
Neutral |
81 |
1 |
Disease |
Decrease |
0.835144 |
|
rs199666264 |
R257P |
4 |
Neutral |
68 |
3 |
Disease |
Decrease |
0.758715 |
|
rs55799839 |
L260P |
4 |
Neutral |
59 |
0 |
Disease |
Decrease |
0.783652 |
|
rs1235644534 |
N44H |
8 |
Neutral |
62 |
1 |
Disease |
Decrease |
0.847527 |
|
rs759420110 |
L571I |
7 |
Neutral |
55 |
1 |
Neutral |
Decrease |
0.605933 |
|
rs749872850 |
E685G |
5 |
Neutral |
83 |
4 |
Disease |
Decrease |
0.895556 |
|
rs747209292 |
K694N |
6 |
Neutral |
77 |
0 |
Disease |
Decrease |
0.810386 |
|
rs201835255 |
R257C |
6 |
Neutral |
65 |
0 |
Disease |
Decrease |
0.764912 |
|
rs766151559 |
F516I |
5 |
Neutral |
91 |
1 |
Disease |
Decrease |
0.530973 |
|
rs368003192 |
R810L |
1 |
Neutral |
88 |
4 |
Disease |
Decrease |
0.723851 |
|
rs769767782 |
V132L |
8 |
Neutral |
52 |
2 |
Neutral |
Decrease |
0.907118 |
|
rs1301599599 |
V32M |
9 |
Neutral |
42 |
6 |
Neutral |
Decrease |
0.814225 |
|
rs199561420 |
S441L |
8 |
Neutral |
62 |
0 |
Neutral |
Increase |
0.767198 |
|
rs56101219 |
I722V |
9 |
Neutral |
83 |
0 |
Neutral |
Decrease |
0.857769 |
|
rs61734367 |
N361D |
8 |
Neutral |
83 |
3 |
Neutral |
Increase |
0.575585 |
|
rs775401427 |
P49S |
6 |
Neutral |
93 |
4 |
Disease |
Decrease |
0.76392 |
|
rs754342091 |
Y98C |
5 |
Neutral |
59 |
3 |
Disease |
Increase |
0.801449 |
|
rs765289408 |
S105C |
7 |
Neutral |
86 |
4 |
Disease |
Increase |
0.60583 |
|
rs972966550 |
L511W |
8 |
Neutral |
93 |
3 |
Disease |
Decrease |
0.570666 |
|
rs1445128804 |
G765D |
6 |
Neutral |
46 |
0 |
Disease |
Decrease |
0.824948 |
|
rs1480203162 |
L375F |
9 |
Neutral |
93 |
1 |
Neutral |
Decrease |
0.780765 |
|
rs1480203162 |
L335F |
6 |
Neutral |
88 |
1 |
Disease |
Decrease |
0.873495 |
|
rs954875750 |
F237S |
7 |
Neutral |
62 |
1 |
Disease |
Decrease |
0.782778 |
|
rs917000574 |
G279S |
9 |
Neutral |
48 |
4 |
Neutral |
Decrease |
0.829709 |
|
rs1256844267 |
T756P |
0 |
Disease |
76 |
6 |
Disease |
Decrease |
0.776527 |
|
rs780472681 |
S762I |
3 |
Neutral |
64 |
5 |
Disease |
Increase |
0.861936 |
|
rs762746728 |
L307F |
8 |
Neutral |
71 |
6 |
Neutral |
Decrease |
0.764051 |
|
rs1353182806 |
G726S |
6 |
Neutral |
52 |
0 |
Neutral |
Decrease |
0.726902 |
|
rs56380595 |
P823T |
5 |
Neutral |
45 |
2 |
Disease |
Decrease |
0.829011 |
|
rs897794510 |
S207C |
9 |
Neutral |
71 |
2 |
Disease |
Increase |
0.521313 |
|
rs902036821 |
D194N |
8 |
Neutral |
68 |
7 |
Neutral |
Decrease |
0.794228 |
|
rs1314441656 |
Q430P |
7 |
Neutral |
65 |
5 |
Disease |
Decrease |
0.758183 |
|
rs1216019140 |
C340W |
7 |
Neutral |
85 |
5 |
Disease |
Decrease |
0.53435 |
|
rs2770144 |
V310G |
7 |
Neutral |
74 |
2 |
Disease |
Decrease |
0.872542 |
|
rs202114774 |
L519V |
9 |
Neutral |
92 |
1 |
Neutral |
Decrease |
0.75702 |
|
rs199632399 |
R745C |
3 |
Neutral |
73 |
6 |
Disease |
Decrease |
0.82176 |
|
rs766243776 |
N309Y |
7 |
Neutral |
84 |
1 |
Disease |
Increase |
0.580148 |
|
rs748810494 |
V134A |
9 |
Neutral |
41 |
4 |
Neutral |
Decrease |
0.843255 |
|
rs202040652 |
T793I |
1 |
Neutral |
88 |
0 |
Neutral |
Decrease |
0.769871 |
|
rs199930089 |
G715S |
0 |
Neutral |
92 |
7 |
Disease |
Decrease |
0.767046 |
|
rs988829747 |
I742T |
4 |
Neutral |
90 |
3 |
Disease |
Decrease |
0.803838 |
|
rs201897073 |
I146T |
7 |
Neutral |
85 |
2 |
Disease |
Decrease |
0.868333 |
|
rs919321567 |
L372Q |
8 |
Neutral |
95 |
3 |
Disease |
Decrease |
0.662393 |
|
rs1394250328 |
I742F |
2 |
Neutral |
77 |
2 |
Disease |
Decrease |
0.788934 |
|
rs376443096 |
D428N |
9 |
Neutral |
54 |
6 |
Neutral |
Increase |
0.531709 |
|
rs1382563975 |
V716M |
7 |
Neutral |
58 |
1 |
Disease |
Decrease |
0.777009 |
|
rs373109368 |
L182V |
8 |
Neutral |
92 |
1 |
Neutral |
Decrease |
0.790967 |
|
rs1388911129 |
L779F |
8 |
Neutral |
89 |
2 |
Disease |
Decrease |
0.833589 |
|
rs200139449 |
G803V |
4 |
Neutral |
51 |
4 |
Disease |
Decrease |
0.556804 |
|
rs1346126850 |
N481D |
4 |
Neutral |
97 |
5 |
Disease |
Decrease |
0.644177 |
|
rs776282454 |
G699R |
7 |
Neutral |
27 |
4 |
Disease |
Decrease |
0.788658 |
|
rs1157906794 |
G715V |
1 |
Disease |
88 |
8 |
Disease |
Decrease |
0.531214 |
|
rs200905500 |
R787H |
6 |
Neutral |
69 |
3 |
Disease |
Decrease |
0.875812 |
|
rs377719663 |
Y709C |
4 |
Neutral |
87 |
6 |
Disease |
Decrease |
0.861331 |
|
rs892362464 |
L59M |
8 |
Neutral |
97 |
2 |
Disease |
Decrease |
0.835298 |
|
rs201521400 |
F237L |
9 |
Neutral |
57 |
1 |
Neutral |
Decrease |
0.761194 |
|
rs199763503 |
L658R |
0 |
Disease |
65 |
4 |
Disease |
Decrease |
0.856749 |
|
rs1194635312 |
Y674C |
0 |
Disease |
79 |
7 |
Disease |
Decrease |
0.759093 |
|
rs754642038 |
V736A |
4 |
Neutral |
98 |
3 |
Disease |
Decrease |
0.863389 |
|
rs777803994 |
L802Q |
5 |
Neutral |
24 |
0 |
Neutral |
Decrease |
0.847852 |
|
rs1363147767 |
G252S |
9 |
Neutral |
37 |
7 |
Neutral |
Decrease |
0.804551 |
|
rs1194292799 |
S455T |
6 |
Neutral |
72 |
0 |
Disease |
Decrease |
0.779176 |
|
rs1194292799 |
S415T |
9 |
Neutral |
52 |
5 |
Neutral |
Increase |
0.709602 |
|
rs80197996 |
L470F |
4 |
Neutral |
83 |
2 |
Disease |
Decrease |
0.652258 |
|
rs200787883 |
F492V |
3 |
Neutral |
95 |
3 |
Disease |
Increase |
0.603573 |
|
rs55905951 |
A676G |
6 |
Neutral |
79 |
2 |
Disease |
Decrease |
0.808704 |
|
rs761598705 |
H708R |
0 |
Disease |
90 |
6 |
Disease |
Increase |
0.697562 |
|
rs750790595 |
R787C |
2 |
Neutral |
80 |
5 |
Disease |
Decrease |
0.858065 |
|
rs769239861 |
R87S |
8 |
Neutral |
37 |
1 |
Neutral |
Decrease |
0.702746 |
|
rs56302444 |
I93V |
9 |
Neutral |
89 |
4 |
Neutral |
Decrease |
0.884007 |
|
rs370421152 |
V134M |
9 |
Neutral |
46 |
2 |
Neutral |
Decrease |
0.826485 |
|
rs188543451 |
L138P |
1 |
Neutral |
97 |
5 |
Disease |
Decrease |
0.806341 |
|
rs993554067 |
L208F |
6 |
Neutral |
81 |
2 |
Disease |
Decrease |
0.604569 |
|
rs2770145 |
C306W |
7 |
Neutral |
66 |
0 |
Disease |
Decrease |
0.751925 |
|
rs770682940 |
N361K |
6 |
Neutral |
87 |
1 |
Disease |
Decrease |
0.66961 |
|
rs765968259 |
N721S |
6 |
Neutral |
81 |
2 |
Disease |
Decrease |
0.554849 |
|
rs1258063271 |
A754V |
3 |
Neutral |
94 |
3 |
Disease |
Decrease |
0.801621 |
|
rs748382304 |
I769T |
4 |
Neutral |
98 |
5 |
Disease |
Decrease |
0.812199 |
|
rs55751501 |
A814T |
6 |
Neutral |
90 |
2 |
Disease |
Decrease |
0.872272 |
|
rs1301599599 |
V32L |
9 |
Neutral |
39 |
7 |
Neutral |
Decrease |
0.675548 |
|
rs201613484 |
L104F |
8 |
Neutral |
99 |
5 |
Disease |
Decrease |
0.846026 |
|
rs200168998 |
I162T |
6 |
Neutral |
95 |
4 |
Disease |
Decrease |
0.763441 |
|
rs77214890 |
D181Y |
7 |
Neutral |
75 |
2 |
Disease |
Increase |
0.664035 |
|
rs759469467 |
I187S |
2 |
Neutral |
97 |
3 |
Disease |
Decrease |
0.885339 |
|
rs1440077974 |
L233S |
5 |
Neutral |
83 |
2 |
Disease |
Decrease |
0.878476 |
|
rs777887873 |
L401Q |
3 |
Neutral |
98 |
5 |
Disease |
Decrease |
0.800966 |
|
rs777887873 |
L401P |
1 |
Disease |
98 |
5 |
Disease |
Decrease |
0.800863 |
|
rs201792813 |
Y652C |
3 |
Neutral |
85 |
7 |
Disease |
Decrease |
0.773517 |
|
rs751229651 |
V678A |
1 |
Neutral |
91 |
5 |
Disease |
Increase |
0.576001 |
|
rs751229651 |
V638A |
8 |
Neutral |
59 |
1 |
Neutral |
Decrease |
0.85106 |
|
rs779420060 |
W687R |
2 |
Neutral |
96 |
9 |
Disease |
Decrease |
0.798396 |
|
rs1174477453 |
V688L |
5 |
Neutral |
90 |
2 |
Disease |
Decrease |
0.735517 |
|
rs1282672274 |
G699V |
4 |
Neutral |
59 |
4 |
Disease |
Decrease |
0.810926 |
|
rs56101219 |
I722F |
2 |
Neutral |
93 |
5 |
Disease |
Decrease |
0.841606 |
|
rs746352626 |
G726D |
1 |
Neutral |
88 |
6 |
Disease |
Decrease |
0.6951 |
|
rs746352626 |
G726V |
3 |
Neutral |
70 |
4 |
Disease |
Decrease |
0.697765 |
|
rs1287623116 |
S744G |
5 |
Neutral |
93 |
5 |
Disease |
Decrease |
0.82433 |
|
rs1048072828 |
T793A |
4 |
Neutral |
92 |
2 |
Disease |
Decrease |
0.792187 |
|
rs779025130 |
C40Y |
5 |
Disease |
96 |
6 |
Disease |
Increase |
0.651774 |
|
rs868027365 |
D84N |
8 |
Neutral |
71 |
0 |
Neutral |
Decrease |
0.710009 |
|
rs760962514 |
D84A |
6 |
Neutral |
90 |
3 |
Disease |
Decrease |
0.66321 |
|
rs1044303225 |
C88R |
6 |
Disease |
96 |
8 |
Disease |
Increase |
0.5 |
|
rs766539584 |
L152V |
7 |
Neutral |
94 |
0 |
Neutral |
Decrease |
0.835198 |
|
rs537921846 |
N160S |
2 |
Neutral |
98 |
3 |
Disease |
Increase |
0.61148 |
|
rs1281579352 |
P168H |
7 |
Neutral |
73 |
3 |
Disease |
Decrease |
0.811214 |
|
rs1296130154 |
N185S |
4 |
Neutral |
98 |
0 |
Disease |
Decrease |
0.805635 |
|
rs371871286 |
N213K |
6 |
Neutral |
88 |
3 |
Disease |
Increase |
0.593595 |
|
rs371871286 |
N173K |
9 |
Neutral |
73 |
1 |
Neutral |
Decrease |
0.781762 |
|
rs202089517 |
S407T |
9 |
Neutral |
63 |
6 |
Neutral |
Decrease |
0.672228 |
|
rs934780727 |
N409S |
5 |
Neutral |
94 |
1 |
Disease |
Decrease |
0.8161 |
|
rs764148809 |
L452R |
1 |
Disease |
92 |
5 |
Disease |
Decrease |
0.817242 |
|
rs201456149 |
D453G |
1 |
Neutral |
86 |
2 |
Disease |
Decrease |
0.759654 |
|
rs1285033378 |
C585Y |
5 |
Disease |
99 |
9 |
Disease |
Increase |
0.791755 |
|
rs1354283847 |
C609Y |
3 |
Disease |
98 |
9 |
Disease |
Decrease |
0.709539 |
|
rs1233324596 |
C609W |
4 |
Disease |
98 |
9 |
Disease |
Decrease |
0.693086 |
|
rs200497661 |
R731Q |
3 |
Disease |
91 |
4 |
Disease |
Decrease |
0.804204 |
Additionally, a comparison of 82 highly conserved mutations in TLR4 proteins was conducted using 10 bioinformatic tools to identify potential conformational changes (Table 4). These analyses provide valuable insights into the potential effects of these SNPs on the TLR4 protein and its function.

Figure 4. 3D Model of TLR4 gene
3.5 Homology modeling and validation of structure
The 3D model of the TLR4 protein was created using a template from the Swiss Model, as the PDB model with ID 5NAO was not fully available. The Swiss Model identified 50 templates, with a 99.64% sequence identity to the query sequence, corresponding to the STML ID Q9TTN0.1.A. This template was used to construct a more complete model of TLR4, focusing on the sequence from amino acids 1 to 839. Specifically, the Alphafold DB model of TLR4_PANPA (gene: TLR4, organism: Pan paniscus) was used for the query sequence. The model's quality and the resulting structure, created using PyMol, are displayed in Figure 4. This 3D model provides a more accurate representation of the TLR4 protein, allowing for further investigation into the impact of mutations on its stability. The TLR4 protein model was refined using GalaxyRefine, resulting in the selection of model 05 as the most refined version. The model's quality was evaluated using QMEAN, yielding a Z-score of -0.81, and a ProSA score was -7.51, both of which were compared to experimental structures of similar size. The final structure adhered to all potential energy calculation constraints, with the majority of amino acid residues (99.64%) located in favorable regions of the RAMACHANDRAN plot. A negative QMEAN Z-score suggests that the protein structure may be unstable. In Figure 5, the refined TLR4 model is highlighted with a red star, indicating its significance and the structural assessment based on these quality metrics. These findings suggest that while the model is refined, it may require further investigation to confirm its stability.

Figure 5. Procheck-RAMACHANDRAN plot (a). QMEAN of the native TLR4 predicted model (b) ProSA plot.
The E31V, R257P, L260P, N44H, R257C, P49S, F237S, S207C, I146T, L182V, L59M, L138P, L208F, I162T, D181Y, I187S, L233S, C40Y, D84A, C88R, N160S, N185S, N213K showed high RMSD values, indicating significant structural changes. SAVES was used to validate the modeled structures, and a RAMACHANDRAN plot analysis was performed to assess the secondary structure of the proteins. The full set of predicted outcomes, including specific details, is provided in Table 2. These results indicate that the modeled mutant proteins are structurally sound, with the majority of residues occupying stable conformations.
Table 4. Structural validation and comparison of TLR4 gene
|
Variation ID |
Mutation |
ERRAT |
Procheck |
Verify |
TM Align |
||
|
Score |
Core |
Allow |
Score |
Tm Score |
RMSD |
||
|
Model |
92.3274 |
0.825 |
0.152 |
0.7521 |
|||
|
rs755813457 |
I320T |
88.8748 |
0.9 |
0.095 |
0.7402 |
0.99852 |
0.38 |
|
rs55786277 |
R804W |
88.539 |
0.895 |
0.096 |
0.7271 |
0.99845 |
0.39 |
|
rs199930089 |
G715R |
88.0503 |
0.889 |
0.105 |
0.7437 |
0.99821 |
0.42 |
|
rs1159116911 |
T151I |
91.2989 |
0.887 |
0.104 |
0.7652 |
0.99842 |
0.39 |
|
rs1163840909 |
E31V |
88.7768 |
0.896 |
0.096 |
0.7664 |
0.99849 |
0.38 |
|
rs1472004859 |
L117S |
89.8862 |
0.899 |
0.093 |
0.7509 |
0.99843 |
0.39 |
|
rs199666264 |
R257P |
90.0504 |
0.89 |
0.1 |
0.7449 |
0.99842 |
0.39 |
|
rs55799839 |
L260P |
86.22 |
0.901 |
0.092 |
0.7521 |
0.99841 |
0.39 |
|
rs1235644534 |
N44H |
87.8635 |
0.897 |
0.093 |
0.7735 |
0.99832 |
0.41 |
|
rs749872850 |
E685G |
91.1504 |
0.893 |
0.1 |
0.7342 |
0.99837 |
0.4 |
|
rs747209292 |
K694N |
91.5723 |
0.89 |
0.105 |
0.7485 |
0.99846 |
0.39 |
|
rs201835255 |
R257C |
90.6566 |
0.89 |
0.103 |
0.7318 |
0.99854 |
0.38 |
|
rs766151559 |
F516I |
92.9114 |
0.886 |
0.102 |
0.7592 |
0.99851 |
0.38 |
|
rs368003192 |
R810L |
89.029 |
0.894 |
0.098 |
0.7461 |
0.99824 |
0.42 |
|
rs775401427 |
P49S |
90.2408 |
0.897 |
0.096 |
0.7735 |
0.99838 |
0.4 |
|
rs754342091 |
Y98C |
89.1414 |
0.892 |
0.096 |
0.7449 |
0.99839 |
0.4 |
|
rs972966550 |
L511W |
89.3805 |
0.891 |
0.098 |
0.758 |
0.99841 |
0.39 |
|
rs1480203162 |
L335F |
88.6076 |
0.894 |
0.098 |
0.7592 |
0.99837 |
0.4 |
|
rs954875750 |
F237S |
87.6106 |
0.891 |
0.102 |
0.7557 |
0.99842 |
0.39 |
|
rs1256844267 |
T756P |
90.7828 |
0.898 |
0.091 |
0.7497 |
0.99837 |
0.4 |
|
rs897794510 |
S207C |
90.4403 |
0.894 |
0.099 |
0.7461 |
0.99828 |
0.41 |
|
rs1314441656 |
Q430P |
87.9093 |
0.886 |
0.102 |
0.7557 |
0.99831 |
0.41 |
|
rs1216019140 |
C340W |
90.2408 |
0.891 |
0.1 |
0.7449 |
0.99835 |
0.4 |
|
rs2770144 |
V310G |
85.7503 |
0.894 |
0.097 |
0.7664 |
0.99835 |
0.4 |
|
rs199632399 |
R745C |
89.3671 |
0.904 |
0.088 |
0.764 |
0.99847 |
0.39 |
|
rs199930089 |
G715S |
88.1313 |
0.887 |
0.105 |
0.7461 |
0.9983 |
0.41 |
|
rs988829747 |
I742T |
85.335 |
0.887 |
0.105 |
76.52% |
0.99834 |
0.4 |
|
rs201897073 |
I146T |
90.404 |
0.894 |
0.101 |
75.21% |
0.99837 |
0.4 |
|
rs919321567 |
L372Q |
88.5101 |
0.898 |
0.097 |
0.7712 |
0.99836 |
0.4 |
|
rs1394250328 |
I742F |
90.4282 |
0.894 |
0.096 |
0.7557 |
0.99843 |
0.39 |
|
rs1382563975 |
V716M |
87.3897 |
0.903 |
0.091 |
0.7747 |
0.99843 |
0.39 |
|
rs373109368 |
L182V |
89.3671 |
0.891 |
0.1 |
0.7676 |
0.99836 |
0.4 |
|
rs1388911129 |
L779F |
90.1141 |
0.899 |
0.092 |
0.7497 |
0.9984 |
0.4 |
|
rs200139449 |
G803V |
90.5303 |
0.893 |
0.101 |
0.7485 |
0.99848 |
0.38 |
|
rs1346126850 |
N481D |
90.7712 |
0.886 |
0.105 |
0.7592 |
0.99835 |
0.4 |
|
rs776282454 |
G699R |
90.7945 |
0.898 |
0.092 |
0.7676 |
0.99847 |
0.39 |
|
rs1157906794 |
G715V |
88.7768 |
0.9 |
0.094 |
0.7616 |
0.99836 |
0.4 |
|
rs200905500 |
R787H |
87.6419 |
0.889 |
0.106 |
0.7783 |
0.99838 |
0.4 |
|
rs377719663 |
Y709C |
88.3838 |
0.887 |
0.102 |
0.7652 |
0.99839 |
0.4 |
|
rs892362464 |
L59M |
88.3692 |
0.889 |
0.101 |
0.7342 |
0.99839 |
0.4 |
|
rs199763503 |
L658R |
90.3676 |
0.89 |
0.102 |
0.7569 |
0.9985 |
0.38 |
|
rs1194635312 |
Y674C |
89.0428 |
0.898 |
0.097 |
0.7485 |
0.99845 |
0.39 |
|
rs777803994 |
L802Q |
89.8734 |
0.891 |
0.098 |
0.7426 |
0.99839 |
0.4 |
|
rs1194292799 |
S455T |
88.1013 |
0.887 |
0.101 |
0.7652 |
0.99837 |
0.4 |
|
rs80197996 |
L470F |
89.5202 |
0.894 |
0.093 |
0.7414 |
0.99835 |
0.4 |
|
rs55905951 |
A676G |
87.3578 |
0.894 |
0.097 |
0.764 |
0.99846 |
0.39 |
|
rs188543451 |
L138P |
87.6904 |
0.896 |
0.093 |
0.7664 |
0.99841 |
0.39 |
|
rs993554067 |
L208F |
90.4943 |
0.892 |
0.1 |
0.7533 |
0.99833 |
0.4 |
|
rs2770145 |
C306W |
90.9091 |
0.896 |
0.096 |
0.7473 |
0.99854 |
0.38 |
|
rs770682940 |
N361K |
90.3797 |
0.9 |
0.091 |
0.7509 |
0.99853 |
0.38 |
|
rs765968259 |
N721S |
88.5932 |
0.896 |
0.095 |
0.7569 |
0.99833 |
0.4 |
|
rs1258063271 |
A754V |
89.7856 |
0.894 |
0.1 |
0.7664 |
0.99833 |
0.4 |
|
rs55751501 |
A814T |
89.8515 |
0.892 |
0.101 |
0.745 |
0.97484 |
0.8 |
|
rs201613484 |
L104F |
92.0354 |
0.894 |
0.101 |
0.7676 |
0.99833 |
0.4 |
|
rs200168998 |
I162T |
90.2532 |
0.885 |
0.106 |
0.7569 |
0.99852 |
0.38 |
|
rs77214890 |
D181Y |
88.8466 |
0.883 |
0.108 |
0.7878 |
0.99851 |
0.38 |
|
rs759469467 |
I187S |
90.5542 |
0.896 |
0.093 |
0.7604 |
0.99834 |
0.4 |
|
rs1440077974 |
L233S |
88.0503 |
0.903 |
0.085 |
0.7723 |
0.99846 |
0.39 |
|
rs777887873 |
L401Q |
86.185 |
0.891 |
0.101 |
0.7437 |
0.99839 |
0.4 |
|
rs777887873 |
L401P |
89.2132 |
0.891 |
0.1 |
0.7604 |
0.99851 |
0.38 |
|
rs751229651 |
V638A |
89.2677 |
0.899 |
0.097 |
0.7533 |
0.99835 |
0.4 |
|
rs779420060 |
W687R |
89.0013 |
0.889 |
0.104 |
0.7521 |
0.99835 |
0.4 |
|
rs1174477453 |
V688L |
89.2541 |
0.899 |
0.093 |
74.85% |
0.99848 |
0.39 |
|
rs1282672274 |
G699V |
89.0704 |
0.895 |
0.098 |
0.7545 |
0.99831 |
0.41 |
|
rs56101219 |
I722F |
89.2405 |
0.894 |
0.097 |
0.7652 |
0.99837 |
0.4 |
|
rs746352626 |
G726D |
91.7513 |
0.895 |
0.096 |
0.733 |
0.99848 |
0.38 |
|
rs746352626 |
G726V |
90.3023 |
0.898 |
0.094 |
0.7414 |
0.99828 |
0.41 |
|
rs1048072828 |
T793A |
88.2724 |
0.891 |
0.101 |
0.7604 |
0.99857 |
0.37 |
|
rs779025130 |
C40Y |
86.6162 |
0.895 |
0.096 |
0.7616 |
0.99838 |
0.4 |
|
rs760962514 |
D84A |
89.029 |
0.891 |
0.104 |
0.7807 |
0.9983 |
0.41 |
|
rs1044303225 |
C88R |
90.2655 |
0.894 |
0.096 |
0.7664 |
0.99835 |
0.4 |
|
rs537921846 |
N160S |
89.2541 |
0.891 |
0.102 |
0.7557 |
0.99838 |
0.4 |
|
rs1296130154 |
N185S |
89.4207 |
0.891 |
0.098 |
0.7545 |
0.99828 |
0.41 |
|
rs371871286 |
N213K |
87.6263 |
0.896 |
0.097 |
0.7664 |
0.9983 |
0.41 |
|
rs371871286 |
N173K |
85.8407 |
0.883 |
0.106 |
0.7449 |
0.99845 |
0.39 |
|
rs934780727 |
N409S |
86.9289 |
0.89 |
0.104 |
0.7533 |
0.99859 |
0.37 |
|
rs764148809 |
L452R |
88.0051 |
0.882 |
0.108 |
0.7497 |
0.99832 |
0.41 |
|
rs201456149 |
D453G |
85.5528 |
0.887 |
0.105 |
0.7688 |
0.99844 |
0.39 |
|
rs1285033378 |
C585Y |
89.0428 |
0.891 |
0.098 |
0.7426 |
0.99834 |
0.4 |
|
rs1354283847 |
C609Y |
85.9316 |
0.891 |
0.1 |
0.7461 |
0.99854 |
0.38 |
|
rs1233324596 |
C609W |
90.621 |
0.899 |
0.091 |
0.7878 |
0.99845 |
0.39 |
|
rs200497661 |
R731Q |
90.2655 |
0.887 |
0.102 |
0.7497 |
0.99851 |
0.38 |
3.6 Structural effect of mutations
Mutation 3D predicts the potential impact of amino acid substitutions on protein structures, as outlined in Table 5. Mutations that are clustered are represented in red, while covered mutations are shown in blue. This visualization helps to distinguish the different types of mutations based on their location and potential structural consequences.
Table 5. Functional prediction of TLR4 protein by Mutation 3D
|
Variation ID |
Mutation |
Mutation 3D Prediction |
|
rs1163840909 |
E31V |
Covered |
|
rs199666264 |
R257P |
Clustered |
|
rs55799839 |
L260P |
Clustered |
|
rs1235644534 |
N44H |
Covered |
|
rs201835255 |
R257C |
Clustered |
|
rs775401427 |
P49S |
Covered |
|
rs954875750 |
F237S |
Clustered |
|
rs897794510 |
S207C |
Clustered |
|
rs201897073 |
I146T |
Clustered |
|
rs373109368 |
L182V |
Clustered |
|
rs892362464 |
L59M |
Covered |
|
rs188543451 |
L138P |
Covered |
|
rs993554067 |
L208F |
Clustered |
|
rs200168998 |
I162T |
Covered |
|
rs77214890 |
D181Y |
Clustered |
|
rs759469467 |
I187S |
Covered |
|
rs1440077974 |
L233S |
Clustered |
|
rs779025130 |
C40Y |
Covered |
|
rs760962514 |
D84A |
Covered |
|
rs1044303225 |
C88R |
Covered |
|
rs537921846 |
N160S |
Clustered |
|
rs1296130154 |
N185S |
Clustered |
|
rs371871286 |
N213K |
Clustered |
Moreover, HOPE predicted the impact of 12 variants on the hydrophobicity, spatial structure, physical and chemical characteristics, and function of the KRT74 protein. According to HOPE, the mutant residue N44H is larger than the wild-type residue, while the mutant residues D84A and N185S are smaller than the wild-type. The effect of the D84A mutation on the protein is considered probably damaging. The location of the N44H mutation is within the protein's domain, while D84A is located in or near highly conserved regions. The S207C mutation is found at homologous sequences, and its effect is predicted to be possibly damaging (Figure 6).

Figure 6. Structural changes of mutant highlighted by HOPE Project.
PyRx program utilized molecular docking to examine ligand-protein interactions, docking 16 selected ligands with TLR4. The binding affinities of these ligands correlate with their activity levels, and all 16 compounds with their respective binding affinities are listed in Table 6. From this, 5 compounds with strong binding affinities (high binding scores) Apigenin, Tetracycline, Tetrodotoxin, S-adenosylmethionine, and Vixotrigine were selected and docked with the native TLR4 protein. For further analysis, Discovery Studio was used, which provides a two-dimensional representation of each docking interaction.
Table 6. Interpretation of docking score highlighted by PyRx between ligands and native protein.
|
Ligands |
Model |
Ligands |
Model |
|
Apigenin |
-6.5 |
SYUIQ-5 |
-6.1 |
|
GAG |
-4.8 |
Tamoxifen |
-5.7 |
|
GN8 |
-5.9 |
Tetrodotoxin |
-6.4 |
|
Riluzole |
-4.9 |
S-adenosylmethionine |
-6.3 |
|
Sclareol |
-5.3 |
Vixotrigine |
-7.1 |
|
Statin |
-5.5 |
Topiramate |
-5.5 |
|
Sinularin |
-5.8 |
Thymol |
-4.7 |
|
Tetracycline |
-7 |
Thymoquione |
-4.9 |
Every ligand selected for docking had a binding free energy greater than -4 kcal/mol, as shown in Table 4. The highest binding energy revealed that the TLR4 protein was successfully docked with Vixotrigine. Vixotrigine and Tetracycline showed the highest binding affinities of -7.1 and -7.0 kcal/mol, respectively, which exceed the affinities of conventional ligand-binding. The Apigenin ligand was fixed in the TLR4 binding pocket sites through conventional Van der Waals interactions with TYR403, GLU376, ARG355, GLU425, ILE450, and TYR451. The Tetracycline ligand was fixed in the TLR4 binding pocket sites through Van der Waals interactions with ASN433, HIS458, THR457, THR459, MET437, LYS435, GLU439, and ALA465. The Tetrodotoxin ligand was fixed in the TLR4 binding pocket sites via Van der Waals interactions with ALA462, MET437, SER438, LEU434, ASN433, GLU439, THR457, and THR459. The S-adenosylmethionine ligand was fixed in the TLR4 binding pocket sites via Van der Waals interactions with ALA610, ASN554, PHE581, LEU553, ARG606, and GLN505. The Vixotrigine ligand was fixed in the TLR4 binding pocket sites through Van der Waals interactions with MET607, PHE581, ALA610, ASP580, LEU553, ASN531, ASN530, and ASN554. Figure 7 displays the interacting residues discovered by docking and compares the interactions between ligand-protein residues in the mutant (N44H, S207C, D84A, N185S) and native TLR4 proteins, highlighting how the mutations alter the functional properties.

Figure 7. Interaction of protein ligands with TLR4 with Apigenin (a), S-adenosylmethionine (b), Tetracycline (c), Tetrodotoxin(d) and (e)Vixotrigine.
The ligands interact with TLR4 protein and play a critical role in modulating its function. TLR4 is involved in the innate immune response and recognizes PAMPs and DAMPs, triggering inflammation and immune activation. 1. Apigenin is known for its anti-inflammatory properties. By binding to TLR4, Apigenin may inhibit the receptor's activation, reducing the inflammatory response. Its interactions with residues like TYR403, GLU376, and ARG355 in the binding pocket can potentially interfere with the downstream signaling pathways, which could help in controlling inflammation. As an antibiotic, Tetracycline can modulate immune responses by interacting with TLR4. It may reduce TLR4-mediated signaling by binding to the receptor and disrupting its function. This could be useful in mitigating excessive immune activation, which is often observed in chronic inflammation and autoimmune diseases. Tetrodotoxin is a potent neurotoxin that blocks sodium channels. Its binding to TLR4 may modulate immune responses by influencing TLR4 signaling, potentially altering the activation of inflammatory pathways. The exact effect of Tetrodotoxin on TLR4 signaling is not fully understood but may involve the inhibition of TLR4-mediated immune responses. S-adenosylmethionine (SAM) is a key molecule involved in methylation reactions and has anti-inflammatory properties. It may modulate TLR4 activity by regulating its signaling pathways, possibly through epigenetic modifications. Its interaction with residues like ALA610, ASN554, and PHE581 may affect the receptor's ability to respond to inflammatory stimuli, thereby reducing the immune response. Vixotrigine, a sodium channel blocker, may have an effect on TLR4-mediated signaling, particularly in inflammatory diseases. Its binding with residues such as MET607, PHE581, and ALA610 could impact the receptor's conformation and reduce the activation of inflammatory pathways, making it a potential therapeutic agent for conditions involving TLR4-driven inflammation. In summary, these ligands can interact with TLR4, potentially altering its structure and function. By either inhibiting or modulating the TLR4 signaling pathway, they may serve as therapeutic agents for diseases driven by excessive or chronic inflammation. The effectiveness of these compounds is further supported by their strong binding affinities and specific interactions with key residues of the TLR4 receptor.
DISCUSSION
Conjunctivitis is a common ophthalmic disease that causes inflammation of the conjunctival tissues. Clinical symptoms include increased discharge, conjunctival congestion, photophobia, and itchy sensations [36]. The nsSNPs are single base variations that alter the encoded protein's amino acid sequence. Studies have examined how nsSNPs affect specific proteins, such as stability and the active sites of enzymes. These investigations 53 examine the different ways that nsSNPs may impact interactions between proteins. Before examining the investigation of nsSNPs from a network viewpoint, we focus on structural alterations that might hinder interaction, changes to disorder, gain of interaction, and post-translational modifications. Here are some instances of nsSNPs at human-pathogen protein-protein interfaces [37].Toll-like receptor 4 (TLR4), expressed in various cells, forms the foundation of the mammalian innate immune system, which is characterized by malfunctioning in different situations [38]. TLR4 SNP is linked to various diseases and dysfunctions in patient populations. TLR4 targeting may not be a cure, impacting drug use and polypharmacy. Its flexibility in binding to various ligands contributes to its flexibility [38]. The study identified 132 missense mutations common in SIFT and Polyhen databases, 82 nsSNPs using 10 repository tools, and analyzed high RMSD mutants using TM align for structural effects. We use computational tools to analyze molecular docking studies to predict protein-ligand interaction and analyze diseases causing SNPs and their impact on protein stability. The study utilized various prediction tools to analyze pathogenic nsSNPs of the TLR4 gene, revealing that 96 out of 132 nsSNPs may be harmful, with 28 SNP variants likely to be benign The predicted SNPs revealed that 104 out of 132 nsSNPs had a negative effect, 28 were neutral, and all 128 SNPs were likely to be damaging. Apart from the possibly damaged Y652C, the benign S415T, I769T, and P168H are also present. SNP &G0 prediction shows that 14 of the 118 substitutions are neutral and linked to illness. The Meta SNP database identified 42 neutral nsSNPs and 90 disease nsSNPs. SuSpect found 132 nsSNPs associated with the disease. Functional analysis revealed that the TLR4 gene has detrimental, potentially damaging effects and a disease effect. These 132 nsSNPs were used to predict the effect of the gene on protein stability. The 132 disease-associated nsSNPs were put in the I-stable to evaluate their effect on protein stability. Since I-stable predicts changes in protein thermal stability, 24 nsSNPs indicated increasing stability and 111 nsSNPs showed decreasing protein thermal stability. Out of 82 nsSNPs in SAVES, 82 mutations were analyzed, but 22 results were shown by 3D mutation. Utilizing a mutation 3D tool, we analyze the functional impact of genetic mutations on disease mechanisms, gene function, and personalized medicine, predicting potential protein function impacts.Out of 82 mutations, we find 1 uncovered mutation, 13 clustered mutations, and 10 covered mutations based on mutation 3D. A more thorough analysis of the 132 nsSNPs is conducted for structural validation. The experimental model for a higher-quality targeted protein structure was validated using various computational programs like TM-Align, verify 3D, SWISS-MODEL, PROCHECK, QMEAN, and ERRAT. The server produced 132 templates, 1 of which was Q9TTN0.1.A., based on the best-aligned template. Our targeted protein's whole sequence was covered by a toll-like receptor. The model, interestingly, fell within the amino acid range of 839, which may be 56 suggesting that the protein sequence surrounding this region is conserved. The Ramachandran plot is a crucial verification matrix as it displays the ?-? torsion angles of the predicted protein backbone. PROCHECK divides the Ramachandran plot into four regions: core, allowed, generously allowed, and disallowed. This allows it to estimate the stereochemical quality of a particular protein structure. The Ramachandran plot's preferred region is described by SWISS-MODEL. Over 90% of core or most favored residues in protein models can be identified with a favorable structure, with scores provided by other computational tools. A QMEAN-Z score of -4.0 or less denotes a low-quality model, while a higher score identifies favorable structural states. Using the TM-align tool, a structural comparison between the wild-type and mutant structures was examined. A high RMSD value and a low TM score both point to structural dissimilarity. The Swiss model indicates that the generated structure is of good quality and suitable for protein-ligand studies. For additional examination, one model and four mutated proteins were chosen based on the validation software's standard score. The PyRx Autodock vina 0.4 software was used to perform docking for 16 drugs and their 5 potential targets. It provided a docking score along with energy minimization values. Out of 16 ligands and 5 protein interactions, the molecular docking studies have revealed that the drug-target interactions of the Model-Apigenin complex were -6.5, the Model-Tetracycline complex was -7.0, the Model-Tetrodotoxin complex was -6.4, the Model-S-adenosylmethionine complex was -6.3, and the Model-Vixotrigine complex was -7.1. These results represent the highest docking scores with energy minimization. The interaction between the ligand and target complex was observed using Discovery Studio Visualizer. A protein's evolutionary conservation profile can be used to gauge how severe a harmful mutation is. 57 Further research is necessary to understand pathogenicity, protein stability, and disease-related nsSNPs. Computational tools will be used in conjunction with wet and dry lab docking analyses of nsSNPs in TLR4 to find novel medications for the treatment of conjunctivitis. When interpreting genetic test results and deciding on a course of treatment, medical professionals can gain from the clinical application of in silico analysis. Experimental research on the functional impact of nsSNPs on immune function is informed by in silico predictions because TLR4 is an essential part of the human immune system. Information about therapeutic targets and the pathophysiology of disease is provided by this method. Computation biologists, physicians, and pharmaceutical companies must collaborate to translate in silico discoveries into clinical applications. Improving patient outcomes and quality of life for people with diseases related to TLR4 is the goal.
In conclusion, through the use of various computational tools, we conducted an in-depth analysis of TLR4 gene SNPs, categorizing them based on their pathogenicity. We found 132 were classified as highly pathogenic and deleterious from 82 missense variants, while the remaining SNPs were considered likely neutral. Structural analysis revealed that these pathogenic variants cause significant disruption to the protein structure and stability, suggesting that they alter the protein function by affecting the normal 3D conformation of the TLR4 protein. Although rs897794510 exhibited similar results for mutant and wild-type sizes, HOPE modeling for variants such as rs199930089, rs1235644534, rs1282672274, rs746352626, and rs760962514 suggested that the mutant size was larger than the wild type. Variants like rs199930089, rs1282672274, and rs746352626 were identified as pathogenic and potentially harmful, while others such as rs368003192 and rs1314441656 were also considered likely harmful. Molecular docking simulations were performed using Pyrx, where the modeled structure of the TLR4 protein was docked with 16 different ligands to predict binding site conformations and ligand orientations. The compounds Vixotrigine, Tetracycline, Apigenin, Tetrodotoxin, and S-adenosylmethionine showed promising binding energy levels. Based on these findings, future research into diseases associated with conjunctivitis should focus on these nsSNPs as primary targets. Since this is the first in-silico study analyzing TLR4 gene variants, it provides a foundation for future experimental studies on diseases related to these polymorphisms. Furthermore, mutational studies could offer deeper insights into the specific functional consequences of these SNPs.
ACKNOWLEDGMENT
We all grateful to our supervisor Dr. Hamna Tariq and our mentor Kainat Ramzan for their guidance in this study.
Funding Information
No Funding
Declaration of Conflict
No Conflict of Interest.
REFERENCES
Tuba Aslam, Humna Tariq*, Muhammad Saleem, Kainat Ramzan*, Khadija Aaliya, Aniqa Aamir, Ali Moazzam Qadri1, Moeen Zulfiqar, Bioinformatic Analysis of Human TLR4 Coding Variations Associated with Ocular Infection: A Structural Prediction and Molecular Docking Studies, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 12, 930-954. https://doi.org/10.5281/zenodo.14325013
10.5281/zenodo.14325013